Articles tagged "Risk factors"

2019 American Transplant Congress
Elevated Visceral Adiposity is Associated with Post-Liver Transplant Mortality and Poorly Correlates with BMI in a Prospective Cohort Study
R. Sharma, R. Rosenblatt, R. Knotts, J. Pisa, E. Verna
Division of Liver Diseases and Transplantation, Columbia Univerisity Medical Center, New York, NY
*Purpose: Obesity is increasingly common in end-stage-liver disease (ESLD). While obesity adversely affects outcomes, whether abnormalities in specific adipose tissue (AT) compartments lead to increased…
2019 American Transplant Congress
Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation
S. Ries,¹, N. J. Skill¹, E. Campbell¹, R. Daniel², C. A. Kubal¹, M. S. Richard¹, M. A. Maluccio¹
¹Surgery, Indiana University, Indianapolis, IN, ²University of Washington, Seattle, WA
*Purpose: Sarcopenia is defined as the loss of muscle mass, typically associated with aging, but frequently appearing in liver disease patients. In particular, sarcopenia present…
2019 American Transplant Congress
The Role of Recipient Weight in Renal Transplantation Revisited; Not Quite the Obesity Paradox
A. Asderakis, R. Tahawar, T. Sabah, U. Khalid, M. Stephens
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom
*Purpose: Studies conflict whether obesity is associated with higher risk of failure and death among kidney transplant recipients. ESRF patients show the obesity paradox where…
2019 American Transplant Congress
Developing a Patient Specific Search: Feedback from Kidney Transplant Candidates and Recipients
W. T. McKinney¹, M. J. Bruin², C. R. Schaffhausen¹, S. Chu², J. Snyder³, A. Matas⁴, B. Kasiske⁵, A. K. Israni¹
¹Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, St. Paul, MN, ³Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN, ⁴Department of Surgery, University of Minnesota, Minneapolis, MN, ⁵Department of Medicine, Hennepin Healthcare, Minneapolis, MN
*Purpose: Patients in need of kidney transplantation face numerous obstacles when identifying a transplant center for treatment. Acceptance criteria, waiting time, and post-transplant allograft survival…
2019 American Transplant Congress
Risk Stratification of Cytomegalovirus Seropositive Kidney Transplant Recipients for CMV Infection
M. M. Azar¹, A. Baghban¹, K. Belfield¹, R. Assi², M. Malinis¹
¹Yale University, New Haven, CT, ²University of Pennsylvania, Philadelphia, PA
*Purpose: Current consensus guidelines for CMV prevention recommend valganciclovir (VGCV) prophylaxis for 3 months after transplantation for CMV R+ kidney transplant recipients (KTR). This standard…
2019 American Transplant Congress
Consideration for Offering Hepatitis C Antibody Positive Donor Grafts to All Patients Listed for Transplant
L. Smith
Vanderbilt Transplant Center, Nashville, TN
*Purpose: Background: The field of organ transplantation continuously struggles with inadequate numbers of donor organs. Therefore, efforts remain focused on increasing organ utilization and expanding…
2019 American Transplant Congress
Paradoxical Differential Post-transplant Rates Of Change Of Serum Proteins In Pediatric Liver Patients With Evidence For A Novel Sarcopenic-dependent Serum Protein Stimulating Factor
C. M. Schmidt¹, J. Molleston², G. S. Rao², C. A. Kubal¹, S. Atoa¹, R. S. Mangus¹
¹Surgery, Transplant Division, Indiana University, Indianapolis, IN, ²Pediatrics, Division of GI and Hepatology, Indiana University, Indianapolis, IN
*Purpose: Pediatric patients with liver disease suffer from hypoalbuminemia, sarcopenia, and malnutrition. This study aims to quantify differential rates of change (ROC) and post-TX normalization…
2019 American Transplant Congress
Assessment of Health-Related Quality of Life and Graft Failure among Kidney Transplant Patients in the Benefit and Benefit-EXT Trials
I. Purnajo¹, J. L. Beaumont¹, M. Polinsky², E. Alemao², M. J. Everly¹
¹Terasaki Research Institute, Los Angeles, CA, ²Bristol Myers Squibb, Princeton, NJ
*Purpose: To achieve patient focused drug development in renal transplant, we need to better understand how the patient’s perspective of health-related quality of life (HRQoL)…
2019 American Transplant Congress
Variations in Recipient and Donor Clinical Characteristics between Kidney Transplant Centers
W. T. McKinney¹, M. Bruin², S. Chu², D. Schladt³, J. Snyder³, A. Matas⁴, B. Kasiske⁵, A. K. Israni³
¹Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, St. Paul, MN, ³Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN, ⁴Department of Surgery, University of Minnesota, Minneapolis, MN, ⁵Department of Medicine, Hennepin Healthcare, Minneapolis, MN
*Purpose: When a patient can choose at which kidney transplant program to establish care, prior knowledge of program acceptance practices (of candidates and donors) can…
2019 American Transplant Congress
A Comparison of the BAR, DRM, DRI, sRRI, ET-DRI, D-MELD and SOFT Score to Predict Outcome after Liver Transplantation in the SRTR Database
J. D. de Boer¹, H. Putter², J. J. Blok¹, I. P. Alwayn¹, B. Van Hoek³, A. E. Braat¹
¹Transplant Center, Leiden University Medical Center, Leiden, Netherlands, ²Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands, ³Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
*Purpose: Several risk models have been developed to predict outcome after liver transplantation (LT) in the last decade. This study analyzes the ability of these…